Adams Respiratory Therapeutics, Inc. 4
4 · Adams Respiratory Therapeutics, Inc. · Filed Oct 4, 2006
Insider Transaction Report
Form 4
Casale Robert Daniel
EVP, Chief Mktg & Devel. Off.
Transactions
- Sale
Common Stock
2006-10-02$36.59/sh−919$33,626→ 0 total - Sale
Common Stock
2006-10-02$36.50/sh−81$2,957→ 919 total - Exercise/Conversion
Stock Option (Right to Buy)
2006-10-02−2,000→ 73,960 totalExercise: $1.42Exp: 2014-02-27→ Common Stock (2,000 underlying) - Sale
Common Stock
2006-10-02$35.10/sh−1,000$35,100→ 1,000 total - Exercise/Conversion
Common Stock
2006-10-02$1.42/sh+2,000$2,840→ 2,000 total
Footnotes (2)
- [F1]The exercise and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2005.
- [F2]The option vests in prorata monthly installments over five years, beginning on April 1, 2004.